Philip P. Boudreau, EVP and CFO of Abbott Laboratories ($ABT), made one open market sale of company shares in the last year, totaling $746,758. His most recent sale occurred on August 8, 2025. Among 11,678 insiders with recent sales, his activity ranks 5,591st by amount, well below the average of $8.59 million over 6.4 transactions. Boudreau reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | EVP AND CFO | F | Common shares without par value | 7441 | $116.26 | 71,538.0000 | 1,996,795,525 | 9.42% | 0.00% |
| Feb. 24, 2026 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | EVP AND CFO | A | Option (right to buy) | 115413 | $0.00 | 115,413.0000 | 1,996,795,525 | 9999.99% | 0.01% |
| Feb. 24, 2026 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | EVP AND CFO | A | Common shares without par value | 27997 | $0.00 | 78,979.0000 | 1,996,795,525 | 54.92% | 0.00% |
| Sept. 1, 2025 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | EVP AND CFO | F | Common shares without par value | 387 | $132.66 | 50,979.0000 | 1,996,448,469 | 0.75% | 0.00% |
| Aug. 8, 2025 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | EVP AND CFO | S | Common shares without par value | 5550 | $134.55 | 51,364.0000 | 1,996,448,469 | 9.75% | 0.00% |
| Feb. 28, 2025 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | EVP AND CFO | F | Common shares without par value | 4908 | $135.87 | 56,913.0000 | 1,991,472,630 | 7.94% | 0.00% |
| Feb. 25, 2025 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | EXECUTIVE VICE PRESIDENT | A | Option (right to buy) | 83783 | $0.00 | 83,783.0000 | 1,991,472,630 | 9999.99% | 0.00% |
| Feb. 25, 2025 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | EXECUTIVE VICE PRESIDENT | A | Common shares without par value | 22495 | $0.00 | 61,821.0000 | 1,991,472,630 | 57.20% | 0.00% |
| Sept. 1, 2024 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | EXECUTIVE VICE PRESIDENT | F | Common shares without par value | 387 | $113.27 | 39,322.0000 | 1,990,029,292 | 0.97% | 0.00% |
| Feb. 29, 2024 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | SENIOR VICE PRESIDENT | F | Common shares without par value | 1738 | $120.05 | 39,706.0000 | 1,987,883,852 | 4.19% | 0.00% |
| Feb. 21, 2024 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | SENIOR VICE PRESIDENT | A | Option (right to buy) | 86519 | $0.00 | 86,519.0000 | 1,987,883,852 | 9999.99% | 0.00% |
| Feb. 21, 2024 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | SENIOR VICE PRESIDENT | A | Common shares without par value | 23024 | $0.00 | 41,444.0000 | 1,987,883,852 | 124.99% | 0.00% |
| Sept. 1, 2023 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | SENIOR VICE PRESIDENT | A | Option (right to buy) | 10223 | $0.00 | 10,223.0000 | 1,986,519,278 | 9999.99% | 0.00% |
| Sept. 1, 2023 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | SENIOR VICE PRESIDENT | A | Common shares without par value | 2620 | $0.00 | 18,416.0000 | 1,986,519,278 | 16.59% | 0.00% |
| June 16, 2023 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | VICE PRESIDENT | S | Common shares without par value | 8000 | $106.00 | 15,794.0000 | 1,986,519,278 | 33.62% | 0.00% |
| Feb. 28, 2023 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | VICE PRESIDENT | F | Common shares without par value | 1477 | $99.77 | 23,793.0000 | 1,986,519,278 | 5.84% | 0.00% |
| Feb. 17, 2023 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | VICE PRESIDENT | A | Option (right to buy) | 19149 | $0.00 | 19,149.0000 | 1,986,519,278 | 9999.99% | 0.00% |
| Feb. 17, 2023 | ABBOTT LABORATORIES | $ABT | Boudreau Philip P | VICE PRESIDENT | A | Common shares without par value | 4855 | $0.00 | 25,270.0000 | 1,986,519,278 | 23.78% | 0.00% |